US20210059597A1 - Sepsis monitoring system - Google Patents
Sepsis monitoring system Download PDFInfo
- Publication number
- US20210059597A1 US20210059597A1 US16/999,315 US202016999315A US2021059597A1 US 20210059597 A1 US20210059597 A1 US 20210059597A1 US 202016999315 A US202016999315 A US 202016999315A US 2021059597 A1 US2021059597 A1 US 2021059597A1
- Authority
- US
- United States
- Prior art keywords
- sepsis
- risk assessment
- assessment score
- sepsis risk
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040047 Sepsis Diseases 0.000 title claims abstract description 202
- 238000012544 monitoring process Methods 0.000 title claims abstract description 41
- 238000012502 risk assessment Methods 0.000 claims abstract description 114
- 230000004044 response Effects 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 41
- 238000003860 storage Methods 0.000 claims description 28
- 230000036387 respiratory rate Effects 0.000 claims description 14
- 238000012806 monitoring device Methods 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 230000036772 blood pressure Effects 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 238000010801 machine learning Methods 0.000 claims description 8
- 230000000116 mitigating effect Effects 0.000 claims description 3
- 238000013517 stratification Methods 0.000 claims description 2
- 206010005746 Blood pressure fluctuation Diseases 0.000 claims 2
- 238000004891 communication Methods 0.000 description 19
- 238000010586 diagram Methods 0.000 description 12
- 238000011157 data evaluation Methods 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 8
- 238000013500 data storage Methods 0.000 description 5
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 108010048233 Procalcitonin Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000000537 electroencephalography Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000097 Abdominal tenderness Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010053555 Arthritis bacterial Diseases 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000015121 Cardiac valve disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 239000003154 D dimer Substances 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020660 Hyperlactacidaemia Diseases 0.000 description 1
- 208000005018 Hyperlactatemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000004575 Infectious Arthritis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000022061 active hyperemia Diseases 0.000 description 1
- 206010069351 acute lung injury Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000012759 altered mental status Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 108010052295 fibrin fragment D Proteins 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000004235 neutropenia Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 201000001223 septic arthritis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009677 vaginal delivery Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6892—Mats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
Definitions
- Sepsis is a life-threatening condition that occurs when the body's response to infection causes injury to its own tissues and organs. Sepsis develops when a pathogen is released into the bloodstream and causes inflammation throughout the entire body.
- the present disclosure relates to a system that continuously updates a sepsis risk assessment score to drive an early intervention by one or more caregivers.
- a sepsis monitoring system comprises a processor and a non-transitory computer-readable storage medium storing instructions that, when executed by the processor, cause the sepsis monitoring system to: determine an initial sepsis risk assessment score; automatically and continuously update the sepsis risk assessment score using a sepsis risk assessment model that receives vital signs data, electronic medical records data, and admissions data to continuously update the sepsis risk assessment score; determine whether the patient is likely to develop sepsis based on the updated sepsis risk assessment score; and in response to determining that the patient is likely to develop sepsis, generate a notification to drive an early intervention by one or more caregivers.
- a method of providing an early intervention for mitigating risks associated with sepsis comprises determining an initial sepsis risk assessment score; continuously receiving measured vital signs from a vital signs monitoring device; automatically and continuously determining an updated sepsis risk assessment score based on at least the measured vital signs; determining whether a patient is likely to develop sepsis based on the updated sepsis risk assessment score; and in response to determining that the patient is likely to develop sepsis, generating a notification to drive an early intervention by one or more caregivers.
- FIG. 1 is a block diagram schematically illustrating a healthcare facility that includes a sepsis monitoring system.
- FIG. 2 is a block diagram schematically illustrating healthcare information systems.
- FIG. 3 is a schematic block diagram of the sepsis monitoring system.
- FIG. 4 illustrates an example method of providing an early intervention.
- FIG. 5 illustrates an example method of building a sepsis risk assessment model.
- FIG. 6 is a schematic diagram of a model building engine.
- FIG. 7 is a schematic diagram of a data evaluation engine.
- FIG. 8 illustrates example physical components of a computing device.
- FIG. 1 is a block diagram schematically illustrating a healthcare facility 100 that includes a sepsis monitoring system 200 .
- the sepsis monitoring system 200 is a clinical decision support tool that automatically and continuously updates a sepsis risk assessment for a patient admitted in the healthcare facility 100 .
- the term “continuous” or “continuously” includes near real-time such that the sepsis risk assessment is updated without perceivable lag.
- the sepsis monitoring system 200 is operably connected to vital signs monitoring devices including at least one of a spot monitor device 102 , a wearable device 104 , and a mattress pad device 106 .
- the sepsis monitoring system 200 is also operably connected to an electronic medical record system 108 and healthcare information systems 110 .
- the healthcare information systems 110 is connected to a plurality of workstations 112 .
- the sepsis monitoring system 200 retrieves data from the spot monitor device 102 , wearable device 104 , mattress pad device 106 , electronic medical record system 108 , and healthcare information systems 110 to continuously determine the sepsis risk assessment.
- the sepsis risk assessment is transmitted from the sepsis monitoring system 200 to the healthcare information systems 110 . Thereafter, the healthcare information systems 110 transmit the sepsis risk assessment for display on the workstations 112 . In alternative embodiments, the sepsis risk assessment is transmitted directly from the sepsis monitoring system 200 to the workstations 112 without using the healthcare information systems 110 as an intermediary for transmitting the sepsis risk assessment to the workstations 112 .
- the healthcare information systems 110 receive data from the sepsis monitoring system 200 (including vital signs data from at least one of the spot monitor device 102 , wearable device 104 , and mattress pad device 106 and data from the electronic medical record system 108 ), and the healthcare information systems 110 calculate the sepsis risk assessment, and transmit the sepsis risk assessment for display on the workstations 112 .
- the sepsis monitoring system 200 acts as a gateway for collecting and transmitting the continuous vital signs to the healthcare information systems 110 .
- the sepsis monitoring system 200 uses a sepsis risk assessment model that receives as an input vital signs data acquired from at least one of the spot monitor device 102 , wearable device 104 , mattress pad device 106 , as well as data from the electronic medical record system 108 and/or healthcare information systems 110 to generate the sepsis risk assessment as an output.
- the vital signs data acquired from at least one of the spot monitor device 102 , wearable device 104 , mattress pad device 106 includes, without limitation, heart rate, respiratory rate, blood pressure, blood oxygen saturation (e.g., SpO2), electrocardiogram data (EKG or ECG), electroencephalography data (EEG), and objective level of pain.
- the sepsis monitoring system 200 is a cloud based system that is hosted over the Internet. In this embodiment, notifications from the sepsis monitoring system 200 are sent to the healthcare information systems 110 and workstations 112 via the Internet.
- the sepsis monitoring system 200 is part of a local area network.
- notifications from the sepsis monitoring system 200 are sent to the healthcare information systems 110 and workstations 112 via the local area network.
- the vital signs monitoring devices including the spot monitor device 102 , wearable device 104 , and mattress pad device 106 , are each configured to continuously, without interruption, measure the vital signs of a patient in the healthcare facility 100 before, during, and after patient rounds by a caregiver.
- the continuous vital sign monitoring can help provide early identification of patient deterioration and drive early intervention by the caregiver.
- the spot monitor device 102 can be mounted onto a mobile stand or can be wall mounted.
- the spot monitor device 102 measures heart rate, respiratory rate, blood pressure, temperature, blood oxygen saturation, and the like.
- the spot monitor device 102 includes WiFi®, Ethernet, or Bluetooth® connectivity to EMR systems.
- the wearable device 104 is a wearable biosensor that continuously measures the vital signs of the patient.
- the wearable device 104 is a specialized vital signs patch (VSP) that continuously measures vital signs including heart rate, respiratory rate, blood pressure, temperature, blood oxygen saturation, and the like.
- VSP vital signs patch
- the mattress pad device 106 is designed for placement under the mattress of a bed where a patient is resting to continuously monitor heart rate and respiratory rate of the patient, and additional physiological parameters such as patient weight and posture.
- the electronic medical record system 108 stores electronic medical records (EMRs). Each EMR contains the medical and treatment history of a patient in the healthcare facility 100 .
- EMRs electronic medical records
- the electronic medical record system 108 receives vital signs data and other physiological parameter data measured by the spot monitor device 102 , wearable device 104 , and mattress pad device 106 via the sepsis monitoring system 200 .
- the healthcare information systems 110 include various systems that are operational within the healthcare facility 100 .
- the healthcare information systems 110 are communicatively connected to the workstations 112 .
- the electronic medical record system 108 is depicted as separate from the healthcare information systems 110 .
- the electronic medical record system 108 is part of the healthcare information systems 110 .
- the workstations 112 include computing devices such as smartphones, tablet computers, laptops, desktop computers, and the like.
- the workstations 112 are used by caregivers in the healthcare facility 100 to access the healthcare information systems 110 , receive notifications from the sepsis monitoring system 200 , and access electronic medical records from the electronic medical record system 108 .
- the number of workstations 112 present in the healthcare facility 100 may vary according to the needs of the healthcare facility 100 .
- the sepsis monitoring system 200 communicates with the spot monitor device 102 , wearable device 104 , mattress pad device 106 , electronic medical record system 108 , and healthcare information systems 110 , and workstations 112 through a wireless connection, a wired connection, or a combination of wireless and wired connections.
- wireless connections include Wi-Fi communication devices that utilize wireless routers or wireless access points, cellular communication devices that utilize one or more cellular base stations, Bluetooth, ANT, ZigBee, medical body area networks, personal communications service (PCS), wireless medical telemetry service (WMTS), and other wireless communication devices and services.
- FIG. 2 is a block diagram schematically illustrating the healthcare information systems 110 .
- the healthcare information systems 110 include a lab system 202 , an Admission, Discharge, and Transfer (ADT) system 204 , a caregiver call system 206 , a database storage 208 , a communications module 210 , and a computing device 1200 .
- ADT Admission, Discharge, and Transfer
- the lab system 202 monitors lab results by recording the date and time a patient sample is taken, sending updates to the caregiver regarding the lab results including when the lab results are ready, and displaying the lab results for review by the caregiver.
- the ADT system 204 provides real-time information on each patient admitted to the healthcare facility 100 including the patient's name, address, gender, room assignment within the healthcare facility 100 , date and time when admitted to and discharged from the healthcare facility 100 , and whether the patient has been transferred to another room or department.
- the caregiver call system 206 generates alerts that are triggered by one or more rules.
- the alerts are sent to the workstations 112 to notify the caregivers for need to perform critical tasks.
- the alerts can be generated based on data from the vital signs monitoring devices including the spot monitor device 102 , wearable device 104 , and mattress pad device 106 , the electronic medical record system 108 , lab system 202 , ADT system 204 , etc.
- patient early warning scores (EWS) when above a predetermined threshold trigger an alert from caregiver call system 206 that is sent to a workstation 112 associated with a caregiver so that the caregiver is notified of the need to perform critical tasks based on the elevated EWS.
- EWS patient early warning scores
- the caregiver call system 206 generates notifications based on the sepsis risk assessment from the sepsis monitoring system 200 which are sent to the workstations 112 .
- the sepsis risk assessment and associated notifications are transmitted directly from the sepsis monitoring system 200 to the workstations 112 without using the caregiver call system 206 as an intermediary.
- the caregiver call system 206 determines the sepsis risk assessment.
- the database storage 208 stores data received from the sepsis monitoring system 200 and electronic medical record system 108 .
- the database storage 208 can also store data from the vital signs monitoring devices including the spot monitor device 102 , wearable device 104 , mattress pad device 106 .
- the database storage 208 stores algorithms and models that are used by the caregiver call system 206 to determine the sepsis risk assessment.
- the communications module 210 enables the various components within the healthcare information systems 110 to communicate with each other, and also with the sepsis monitoring system 200 , electronic medical record system 108 , and workstations 112 .
- the communications module 210 enables the caregiver call system 206 to act as a dispatch system to instruct caregivers when an intervention is warranted.
- the communications module 210 provides a communication link, such as audio or video, between the patient and caregivers.
- Communication devices including telephone and other voice communication devices worn by the caregivers enable the communications module 210 to provide direct communication between the caregivers and the patient.
- the computing device 1200 processes data from the database storage 208 , and communicates with the lab system 202 , ADT system 204 , caregiver call system 206 , and communications module 210 .
- the computing device 1200 includes at least one processor that executes instructions to implement one or more of the methods described herein. The computing device 1200 is described in more detail with reference to FIG. 8 .
- FIG. 3 is a schematic block diagram of the sepsis monitoring system 200 .
- the sepsis monitoring system 200 is used to automatically and continuously estimate a likelihood for a given patient to develop sepsis. This likelihood can be used, as described herein, to mitigate risks and costs associated with sepsis through early intervention by caregivers.
- the sepsis monitoring system 200 can be used to predict a likelihood of the patient developing sepsis 6-12 hours before the onset of sepsis.
- the sepsis monitoring system 200 includes a model building engine 302 , a data evaluation engine 304 , a notification engine 306 , a communications module 308 , a database storage 310 , and a computing device 1200 .
- the database storage 310 stores data from the electronic medical record system 108 , healthcare information systems 110 , and the vital signs monitoring devices including the spot monitor device 102 , wearable device 104 , and mattress pad device 106 .
- the database storage 310 is a critical data repository (CDR).
- the data stored in the database storage 310 is used for machine learning and algorithm development.
- the model building engine 302 operates to build a model that can be used by the sepsis monitoring system 200 to automatically and continuously estimate a likelihood for a given patient to develop sepsis.
- the model building engine 302 uses the data stored in the database storage 310 to build the model.
- the model building engine 302 uses one or more machine learning techniques to build the model. Example methods performed by some embodiments of the model building engine 302 are illustrated and described with respect to FIGS. 5 and 6 .
- the data evaluation engine 304 operates to continuously evaluate data from at least one vital signs monitoring device such as, without limitation, at least one of the spot monitor device 102 , wearable device 104 , mattress pad device 106 , and the like to determine a sepsis risk assessment score.
- the data evaluation engine 304 also operates to continuously evaluate data from the electronic medical record system 108 and healthcare information systems 110 to determine a sepsis risk assessment score.
- the data evaluation engine 304 uses the model built by the model building engine 302 to automatically and continuously determine the sepsis risk assessment score.
- the sepsis risk assessment score predicts whether a patient is likely to develop sepsis. Example methods performed by some embodiments of the data evaluation engine 304 are illustrated and described in more detail with respect to at least FIG. 7 .
- the notification engine 306 operate to generate one or more types of notifications to alert caregivers that the patient is likely to develop sepsis when the sepsis risk assessment score exceeds a threshold value, or if the sepsis risk assessment score is classified as a high risk or medium risk.
- the notification drives early intervention by the caregivers to mitigate the risks and costs associated with sepsis.
- the notification generated by the notification engine 306 may be delivered in any suitable form, including audible, visual, and textual such as a text message, pager message, email, or other form of alert, such as a message on the workstations 112 .
- the communications module 308 enables the sepsis monitoring system 200 to communicate with the vital signs monitoring devices including the spot monitor device 102 , wearable device 104 , and mattress pad device 106 , and with the electronic medical record system 108 , healthcare information systems 110 , and workstations 112 in the healthcare facility 100 .
- the sepsis monitoring system 200 can communicate with these devices and systems through a wireless connection, a wired connection, or a combination of wireless and wired connections.
- the computing device 1200 processes the data from the database storage 310 , and communicates with the model building engine 302 , data evaluation engine 304 , notification engine 306 , and communications module 308 .
- the computing device 1200 includes at least one processor that executes instructions to implement one or more of the methods described herein.
- FIG. 4 illustrates an example method 400 of providing an early intervention for mitigating the risks and costs associated with sepsis.
- the method 400 at operation 402 includes determining an initial sepsis risk assessment score for a patient admitted to a healthcare facility.
- the sepsis risk assessment score predicts a likelihood of the patient developing sepsis while admitted in the facility.
- the score can be classified as low risk, medium risk, or high risk. Alternatively, the score can be numerical such as based on a scale between 0-100.
- a sepsis risk assessment model is used to determine the sepsis risk assessment score.
- the sepsis risk assessment score is displayed in a mobile platform operable on a portable device such as a tablet computer, smartphone, and the like.
- a portable device such as a tablet computer, smartphone, and the like.
- the sepsis risk assessment score can also be displayed as an EMR plug-in.
- the method 400 at operation 404 includes connecting the patient to at least one vital signs monitoring devices such as a spot monitor device, wearable device, or mattress pad device to continuously measure the vital signs of the patient.
- at least one vital signs monitoring devices such as a spot monitor device, wearable device, or mattress pad device to continuously measure the vital signs of the patient.
- the method 400 at operation 406 includes automatically and continuously updating the sepsis risk assessment score for the patient.
- the sepsis risk assessment model is used to automatically and continuously update the sepsis risk assessment score.
- the sepsis risk assessment score is automatically and continuously updated using the continuously measured vital signs of the patient from at least one of the vital signs monitoring devices, as well as using additional physiological parameters and information from an electronic medical record system.
- the sepsis risk assessment score is automatically and continuously updated using data from the electronic medical record system.
- the method 400 determines whether the patient is likely to develop sepsis based on the continuously updated sepsis risk assessment score. If the sepsis risk assessment score is less than a threshold value, or if the score is classified as a low risk (i.e., “No” in operation 408 ), the method 400 returns to continuously updating the sepsis risk score (i.e., operation 406 ). If the sepsis risk assessment score exceeds a threshold value, or if the score is classified as a high risk or medium risk (i.e., “Yes” in operation 408 ), a notification is generated at operation 410 to alert the caregivers that the patient is likely to develop sepsis.
- a notification is delivered in any suitable form.
- the notification can include audible, visual, and textual alerts such as text messages, pager messages, emails, or other forms of an alert, such as a message on a display device that is viewable by one or more caregivers.
- the notification can indicate that a certain action should be taken by a caregiver.
- the notification can indicate that the caregiver should go check on the patient in-person, confirm the vital signs data, or order a lactate lab.
- the notification is displayed in a mobile platform operable on a portable device such as a tablet computer, smartphone, and the like.
- a portable device such as a tablet computer, smartphone, and the like.
- the notification is also displayed as an EMR plug-in that is accessible from a workstation.
- the notification from operation 410 drives an early intervention to treat the patient and mitigate the risks and costs associated with sepsis.
- the early intervention can include providing antibiotics, fluids, taking additional laboratory tests, and other supportive medical interventions.
- FIG. 5 illustrates a method 500 of building the sepsis risk assessment model for automatically and continuously determining a sepsis risk assessment score that is performed by some embodiments of the model building engine 302 (see FIG. 3 ).
- the method 500 can be used, for example, to build a model for determining an initial sepsis risk assessment score for a patient admitted to a healthcare facility such as in operation 402 of the method 400 (see FIG. 4 ) and also for automatically and continuously updating the sepsis risk assessment score for the patient such as in operation 406 of the method 400 described above (see FIG. 4 ).
- sepsis risk factor data is acquired.
- the sepsis risk factor data includes vital signs data (e.g., data acquired from at least one of the vital signs monitoring devices of FIG. 1 ), electronic medical records data (e.g., data acquired from the EMR system 108 of FIG. 1 ), laboratory data (e.g., data acquired from the lab system 202 of FIG. 2 ), and admissions data (e.g., data acquired from the ADT system 204 of FIG. 2 ).
- the sepsis risk factor data is associated with septic patients and with non-septic patients.
- the communications module 308 of the sepsis monitoring system 200 is utilized to acquire the sepsis risk factor data from the data sources within the healthcare facility 100 .
- the sepsis risk assessment model is built using the acquired sepsis risk factor data.
- the sepsis risk assessment model is initially developed using a retrospective analysis of a database that includes the EMR data, lab data, ADT data, and vital signs data.
- the database storage 310 of the sepsis monitoring system 200 is utilized to store the EMR data, lab data, ADT data, and vital signs data for performing the retrospective analysis.
- the model building engine 302 of the sepsis monitoring system 200 is utilized to build the sepsis risk assessment model.
- FIG. 6 is a schematic diagram of the model building engine 302 that receives first and second sets of inputs 602 , 606 to build a sepsis risk assessment model 610 as an output.
- the first set of inputs 602 include acquired sepsis risk factor data 604 associated with septic patients.
- the second set of inputs 606 include acquired sepsis risk factor data 608 associated with non-septic patients.
- the acquired sepsis risk factor data 604 , 608 is seed data used by the model building engine 302 to build the sepsis risk assessment model 610 .
- the acquired sepsis risk factor data 604 can be used as positive training examples while the acquired sepsis risk factor data 608 can be used as negative training examples to build the sepsis risk assessment model 610 using one or more machine learning techniques.
- the sepsis risk assessment model 610 is built using supervised machine learning techniques such as a logistic regression.
- the sepsis risk assessment model 610 is built using unsupervised machine learning techniques such as neural networks.
- the sepsis risk assessment model 610 can be built by tree based methods such as gradient boosting machine learning techniques, and the like.
- FIG. 7 is a schematic diagram of the data evaluation engine 304 .
- the data evaluation engine 304 receives as an input 702 sepsis risk factor data 704 for a given patient.
- the data evaluation engine 304 uses the sepsis risk assessment model 610 to generate as an output a sepsis risk assessment score 706 that predicts whether the patient is likely to develop sepsis.
- the sepsis risk factor data 704 is automatically and continuously evaluated by the data evaluation engine 304 using the sepsis risk assessment model 610 to continuously determine the sepsis risk assessment score 706 while the patient is admitted to the healthcare facility.
- the sepsis risk assessment score 706 is calculated by the spot monitor 102 of FIG. 1 .
- the sepsis risk assessment score 706 can be calculated by the sepsis monitoring system 200 which is a cloud based system that can connect to the spot monitor 102 .
- the sepsis risk factor data 704 includes measured vital signs data including heart rate, respiratory rate, blood pressure, or blood oxygen saturation data.
- the sepsis risk factor data 704 may also include data such as temperature and mean arterial pressure (MAP), and derived parameters such as shock index (SI) which is an assessment defined as heart rate divided by systolic blood pressure, and estimated cardiac output calculations.
- MAP temperature and mean arterial pressure
- SI shock index
- the sepsis risk factor data 704 may also include mobility data measured from an accelerometer patch or bed load cell sensors.
- sepsis risk assessment score 706 is based on a change over time, a standard deviation, a maximum value, or a difference from a 24 hour moving average in the data. In some examples, the sepsis risk assessment score 706 is based on a change in heart rate, respiratory rate, blood pressure, or blood oxygen saturation above or below a baseline level.
- the sepsis risk assessment score 706 is classified in a risk stratification as a low risk, a medium risk, or a high risk. In alternative embodiments, the sepsis risk assessment score 706 is calculated as a numerical value.
- a classifier in addition to calculating the sepsis risk assessment score 706 , a classifier is generated to identify a trend in the sepsis risk assessment score 706 such as an increase or decrease in the sepsis risk assessment score 706 .
- the classifier can be a symbol such as an upward arrow to indicate an increasing score and a downward arrow to indicate a decreasing score, or a color such as red to indicate an increasing score and green to indicate a decreasing score.
- the sepsis risk assessment score 706 can be trended according to mean, minimum, maximum, difference between minimum and maximum, standard deviation, first calculation, last calculation, different between first and last calculation, difference between last calculation and calculation performed 1, 2, 4, 12, 24, or 72 hours ago, frequency of the calculations (i.e., was the calculation taken and how often?).
- a linear regression trend, a quadratic regression trend, skewness (i.e., a measure of the asymmetry of the probability distribution of a real-valued random variable about its mean), and kurtosis (i.e., a measure of the tails of the probability distribution of a real-valued random variable) can be calculated for analyzing trends in the sepsis risk assessment score 706 .
- the sepsis risk assessment score 706 is generated in a manner to prevent alarm fatigue.
- the sepsis risk assessment score 706 can be compared to a threshold value specific to the patient (e.g., based upon the patient's prior history) or can be compared to a general threshold value associated with the patient's demographic (e.g., age, sex, etc.).
- a threshold value specific to the patient (e.g., based upon the patient's prior history) or can be compared to a general threshold value associated with the patient's demographic (e.g., age, sex, etc.).
- a notification is generated by the notification engine 306 to alert the caregivers that the patient is likely to develop sepsis.
- the notification drives an early intervention by the caregivers to mitigate the risks and costs associated with sepsis.
- the sepsis risk assessment score 706 is continuously determined in near-real-time, such as every second, or every five seconds, or every minute, etc. Additionally, by automatically retrieving continuous data from the vital signs monitoring devices, electronic medical record system 108 , and healthcare information systems 110 , the sepsis risk assessment score 706 is calculated using additional factors not used to calculate the SIRS, SOFA, and qSOFA scores.
- SIRS Systemic inflammatory response syndrome
- SOFA Sequential Organ Failure Assessment
- qSOFA quick SOFA
- the sepsis risk assessment score 706 is also more refined and accurate over the SIRS, SOFA, and qSOFA scores which are based only on a limited number of factors.
- the sepsis risk assessment score 706 is calculated using risk factors including continuous vital signs and physiological data, laboratory data, clinical examination data, medications data, admissions data, and the like.
- the sepsis risk assessment score 706 may also be calculated using risk factors such as comorbidities, and recent medical procedures, operations, invasive medical devices, and other patient historical data.
- the sepsis risk assessment score 706 is calculated using data from point of care devices such as, for example, a handheld blood analyzer that provides real-time measurements for lactate, glucose, procalcitonin, arterial blood gases, and similar parameters.
- At least some of the risk factors which contribute to the sepsis risk assessment score 706 are summarized in Table 1. These risk factors are not exhaustive, and are provided as illustrative examples of the types of data that can be used to calculate the sepsis risk assessment score 706 .
- FIG. 8 illustrates example physical components of a computing device 1200 , such as the computing device or devices used to implement aspects of the disclosure described above.
- the computing device 1200 includes at least one processor or central processing unit (“CPU”) 1208 , a system memory 1212 , and a system bus 1210 that couples the system memory 1212 to the CPU 1208 .
- the central processing unit 1208 is an example of a processing device.
- the system memory 1212 includes a random access memory (“RAM”) 1218 and a read-only memory (“ROM”) 1220 .
- RAM random access memory
- ROM read-only memory
- the computing device further includes a mass storage device 1214 .
- the mass storage device 1214 is able to store software instructions and data.
- the mass storage device 1214 is connected to the CPU 1208 through the system bus 1210 .
- the mass storage device 1214 and its associated computer-readable data storage media provide non-volatile, non-transitory storage for the computing device.
- computer-readable data storage media can be any available non-transitory, physical device or article of manufacture from which the device can read data and/or instructions.
- the mass storage device 1214 is an example of a computer-readable storage device.
- Computer-readable data storage media include volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable software instructions, data structures, program modules or other data.
- Example types of computer-readable data storage media include, but are not limited to, RAM, ROM, EPROM, EEPROM, flash memory or other solid-state memory technology, CD-ROMs, digital versatile discs (“DVDs”), other optical storage media, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by the computing device.
- the computing device 1200 may operate in a networked environment using logical connections to remote network devices through a network 46 , such as a local network, the Internet, or another type of network.
- the computing device 1200 connects to the network 46 through a network interface unit 1216 connected to the system bus 1210 .
- the network interface unit 1216 may also connect to other types of networks and remote computing systems.
- the computing device 1200 includes an input/output unit 1222 for receiving and processing input from a number of other devices, including a touch user interface display screen, or another type of input device. Similarly, the input/output unit 1222 may provide output to a touch user interface display screen, a printer, or other type of output device.
- the mass storage device 1214 and the RAM 1218 of the computing device 1200 can store software instructions and data.
- the software instructions include an operating system 1232 suitable for controlling the operation of the computing device 1200 .
- the mass storage device 1214 and/or the RAM 1218 also store software instructions, that when executed by the CPU 1208 , cause the computing device 1200 to provide the functionality discussed in this document, including the methods described herein.
- Communication media may be embodied in the software instructions, data structures, program modules, or other data in a modulated data signal, such as a carrier wave or other transport mechanism, and includes any information delivery media.
- modulated data signal may describe a signal that has one or more characteristics set or changed in such a manner as to encode information in the signal.
- communication media may include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, radio frequency (RF), infrared, and other wireless media.
- RF radio frequency
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Signal Processing (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
- Sepsis is a life-threatening condition that occurs when the body's response to infection causes injury to its own tissues and organs. Sepsis develops when a pathogen is released into the bloodstream and causes inflammation throughout the entire body.
- Sepsis at its earliest stages is usually reversible with antibiotics, fluids, and other supportive medical interventions. However, as time progresses the risk of dying increases substantially. Therefore, early detection of sepsis is desirable.
- In general terms, the present disclosure relates to a system that continuously updates a sepsis risk assessment score to drive an early intervention by one or more caregivers.
- In one aspect, a sepsis monitoring system comprises a processor and a non-transitory computer-readable storage medium storing instructions that, when executed by the processor, cause the sepsis monitoring system to: determine an initial sepsis risk assessment score; automatically and continuously update the sepsis risk assessment score using a sepsis risk assessment model that receives vital signs data, electronic medical records data, and admissions data to continuously update the sepsis risk assessment score; determine whether the patient is likely to develop sepsis based on the updated sepsis risk assessment score; and in response to determining that the patient is likely to develop sepsis, generate a notification to drive an early intervention by one or more caregivers.
- In another aspect, a method of providing an early intervention for mitigating risks associated with sepsis comprises determining an initial sepsis risk assessment score; continuously receiving measured vital signs from a vital signs monitoring device; automatically and continuously determining an updated sepsis risk assessment score based on at least the measured vital signs; determining whether a patient is likely to develop sepsis based on the updated sepsis risk assessment score; and in response to determining that the patient is likely to develop sepsis, generating a notification to drive an early intervention by one or more caregivers.
- These and other aspects and embodiments are described in detail below, in relation to the attached drawing figures.
- The following drawing figures, which form a part of this application, are illustrative of the described technology and are not meant to limit the scope of the disclosure in any manner.
-
FIG. 1 is a block diagram schematically illustrating a healthcare facility that includes a sepsis monitoring system. -
FIG. 2 is a block diagram schematically illustrating healthcare information systems. -
FIG. 3 is a schematic block diagram of the sepsis monitoring system. -
FIG. 4 illustrates an example method of providing an early intervention. -
FIG. 5 illustrates an example method of building a sepsis risk assessment model. -
FIG. 6 is a schematic diagram of a model building engine. -
FIG. 7 is a schematic diagram of a data evaluation engine. -
FIG. 8 illustrates example physical components of a computing device. -
FIG. 1 is a block diagram schematically illustrating ahealthcare facility 100 that includes asepsis monitoring system 200. Thesepsis monitoring system 200 is a clinical decision support tool that automatically and continuously updates a sepsis risk assessment for a patient admitted in thehealthcare facility 100. As used herein, the term “continuous” or “continuously” includes near real-time such that the sepsis risk assessment is updated without perceivable lag. - The
sepsis monitoring system 200 is operably connected to vital signs monitoring devices including at least one of aspot monitor device 102, awearable device 104, and amattress pad device 106. Thesepsis monitoring system 200 is also operably connected to an electronicmedical record system 108 andhealthcare information systems 110. Thehealthcare information systems 110 is connected to a plurality ofworkstations 112. - The
sepsis monitoring system 200 retrieves data from thespot monitor device 102,wearable device 104,mattress pad device 106, electronicmedical record system 108, andhealthcare information systems 110 to continuously determine the sepsis risk assessment. - In some embodiments, the sepsis risk assessment is transmitted from the
sepsis monitoring system 200 to thehealthcare information systems 110. Thereafter, thehealthcare information systems 110 transmit the sepsis risk assessment for display on theworkstations 112. In alternative embodiments, the sepsis risk assessment is transmitted directly from thesepsis monitoring system 200 to theworkstations 112 without using thehealthcare information systems 110 as an intermediary for transmitting the sepsis risk assessment to theworkstations 112. - In alternative embodiments, the
healthcare information systems 110 receive data from the sepsis monitoring system 200 (including vital signs data from at least one of thespot monitor device 102,wearable device 104, andmattress pad device 106 and data from the electronic medical record system 108), and thehealthcare information systems 110 calculate the sepsis risk assessment, and transmit the sepsis risk assessment for display on theworkstations 112. In these embodiments, thesepsis monitoring system 200 acts as a gateway for collecting and transmitting the continuous vital signs to thehealthcare information systems 110. - The
sepsis monitoring system 200 uses a sepsis risk assessment model that receives as an input vital signs data acquired from at least one of thespot monitor device 102,wearable device 104,mattress pad device 106, as well as data from the electronicmedical record system 108 and/orhealthcare information systems 110 to generate the sepsis risk assessment as an output. The vital signs data acquired from at least one of thespot monitor device 102,wearable device 104,mattress pad device 106 includes, without limitation, heart rate, respiratory rate, blood pressure, blood oxygen saturation (e.g., SpO2), electrocardiogram data (EKG or ECG), electroencephalography data (EEG), and objective level of pain. - In one embodiment, the
sepsis monitoring system 200 is a cloud based system that is hosted over the Internet. In this embodiment, notifications from thesepsis monitoring system 200 are sent to thehealthcare information systems 110 andworkstations 112 via the Internet. - In an alternative embodiment, the
sepsis monitoring system 200 is part of a local area network. In this example embodiment, notifications from thesepsis monitoring system 200 are sent to thehealthcare information systems 110 andworkstations 112 via the local area network. - The vital signs monitoring devices, including the
spot monitor device 102,wearable device 104, andmattress pad device 106, are each configured to continuously, without interruption, measure the vital signs of a patient in thehealthcare facility 100 before, during, and after patient rounds by a caregiver. The continuous vital sign monitoring can help provide early identification of patient deterioration and drive early intervention by the caregiver. - The
spot monitor device 102 can be mounted onto a mobile stand or can be wall mounted. Thespot monitor device 102 measures heart rate, respiratory rate, blood pressure, temperature, blood oxygen saturation, and the like. In some examples, thespot monitor device 102 includes WiFi®, Ethernet, or Bluetooth® connectivity to EMR systems. - The
wearable device 104 is a wearable biosensor that continuously measures the vital signs of the patient. In some examples, thewearable device 104 is a specialized vital signs patch (VSP) that continuously measures vital signs including heart rate, respiratory rate, blood pressure, temperature, blood oxygen saturation, and the like. - The
mattress pad device 106 is designed for placement under the mattress of a bed where a patient is resting to continuously monitor heart rate and respiratory rate of the patient, and additional physiological parameters such as patient weight and posture. - The electronic
medical record system 108 stores electronic medical records (EMRs). Each EMR contains the medical and treatment history of a patient in thehealthcare facility 100. In some embodiments, the electronicmedical record system 108 receives vital signs data and other physiological parameter data measured by thespot monitor device 102,wearable device 104, andmattress pad device 106 via thesepsis monitoring system 200. - The
healthcare information systems 110, which are described in more detail with reference toFIG. 2 , include various systems that are operational within thehealthcare facility 100. Thehealthcare information systems 110 are communicatively connected to theworkstations 112. In the example embodiment ofFIG. 1 , the electronicmedical record system 108 is depicted as separate from thehealthcare information systems 110. In alternative example embodiments, the electronicmedical record system 108 is part of thehealthcare information systems 110. - The
workstations 112 include computing devices such as smartphones, tablet computers, laptops, desktop computers, and the like. Theworkstations 112 are used by caregivers in thehealthcare facility 100 to access thehealthcare information systems 110, receive notifications from thesepsis monitoring system 200, and access electronic medical records from the electronicmedical record system 108. The number ofworkstations 112 present in thehealthcare facility 100 may vary according to the needs of thehealthcare facility 100. - The
sepsis monitoring system 200 communicates with thespot monitor device 102,wearable device 104,mattress pad device 106, electronicmedical record system 108, andhealthcare information systems 110, andworkstations 112 through a wireless connection, a wired connection, or a combination of wireless and wired connections. Examples of wireless connections include Wi-Fi communication devices that utilize wireless routers or wireless access points, cellular communication devices that utilize one or more cellular base stations, Bluetooth, ANT, ZigBee, medical body area networks, personal communications service (PCS), wireless medical telemetry service (WMTS), and other wireless communication devices and services. -
FIG. 2 is a block diagram schematically illustrating thehealthcare information systems 110. As shown inFIG. 2 , thehealthcare information systems 110 include alab system 202, an Admission, Discharge, and Transfer (ADT)system 204, acaregiver call system 206, adatabase storage 208, acommunications module 210, and acomputing device 1200. - The
lab system 202 monitors lab results by recording the date and time a patient sample is taken, sending updates to the caregiver regarding the lab results including when the lab results are ready, and displaying the lab results for review by the caregiver. - The
ADT system 204 provides real-time information on each patient admitted to thehealthcare facility 100 including the patient's name, address, gender, room assignment within thehealthcare facility 100, date and time when admitted to and discharged from thehealthcare facility 100, and whether the patient has been transferred to another room or department. - The
caregiver call system 206 generates alerts that are triggered by one or more rules. The alerts are sent to theworkstations 112 to notify the caregivers for need to perform critical tasks. The alerts can be generated based on data from the vital signs monitoring devices including thespot monitor device 102,wearable device 104, andmattress pad device 106, the electronicmedical record system 108,lab system 202,ADT system 204, etc. As an illustrative example, patient early warning scores (EWS) when above a predetermined threshold trigger an alert fromcaregiver call system 206 that is sent to aworkstation 112 associated with a caregiver so that the caregiver is notified of the need to perform critical tasks based on the elevated EWS. - In some embodiments, the
caregiver call system 206 generates notifications based on the sepsis risk assessment from thesepsis monitoring system 200 which are sent to theworkstations 112. In alternative embodiments, the sepsis risk assessment and associated notifications are transmitted directly from thesepsis monitoring system 200 to theworkstations 112 without using thecaregiver call system 206 as an intermediary. In yet further alternative embodiments, thecaregiver call system 206 determines the sepsis risk assessment. - The
database storage 208 stores data received from thesepsis monitoring system 200 and electronicmedical record system 108. Thedatabase storage 208 can also store data from the vital signs monitoring devices including thespot monitor device 102,wearable device 104,mattress pad device 106. In some example embodiments, thedatabase storage 208 stores algorithms and models that are used by thecaregiver call system 206 to determine the sepsis risk assessment. - The
communications module 210 enables the various components within thehealthcare information systems 110 to communicate with each other, and also with thesepsis monitoring system 200, electronicmedical record system 108, andworkstations 112. - The
communications module 210 enables thecaregiver call system 206 to act as a dispatch system to instruct caregivers when an intervention is warranted. In some examples, thecommunications module 210 provides a communication link, such as audio or video, between the patient and caregivers. Communication devices including telephone and other voice communication devices worn by the caregivers enable thecommunications module 210 to provide direct communication between the caregivers and the patient. - The
computing device 1200 processes data from thedatabase storage 208, and communicates with thelab system 202,ADT system 204,caregiver call system 206, andcommunications module 210. Thecomputing device 1200 includes at least one processor that executes instructions to implement one or more of the methods described herein. Thecomputing device 1200 is described in more detail with reference toFIG. 8 . -
FIG. 3 is a schematic block diagram of thesepsis monitoring system 200. In a general sense, thesepsis monitoring system 200 is used to automatically and continuously estimate a likelihood for a given patient to develop sepsis. This likelihood can be used, as described herein, to mitigate risks and costs associated with sepsis through early intervention by caregivers. As an illustrative example, thesepsis monitoring system 200 can be used to predict a likelihood of the patient developing sepsis 6-12 hours before the onset of sepsis. Thesepsis monitoring system 200 includes amodel building engine 302, adata evaluation engine 304, anotification engine 306, acommunications module 308, adatabase storage 310, and acomputing device 1200. - The
database storage 310 stores data from the electronicmedical record system 108,healthcare information systems 110, and the vital signs monitoring devices including thespot monitor device 102,wearable device 104, andmattress pad device 106. In some examples, thedatabase storage 310 is a critical data repository (CDR). In some embodiments, the data stored in thedatabase storage 310 is used for machine learning and algorithm development. - The
model building engine 302 operates to build a model that can be used by thesepsis monitoring system 200 to automatically and continuously estimate a likelihood for a given patient to develop sepsis. Themodel building engine 302 uses the data stored in thedatabase storage 310 to build the model. Themodel building engine 302 uses one or more machine learning techniques to build the model. Example methods performed by some embodiments of themodel building engine 302 are illustrated and described with respect toFIGS. 5 and 6 . - The
data evaluation engine 304 operates to continuously evaluate data from at least one vital signs monitoring device such as, without limitation, at least one of thespot monitor device 102,wearable device 104,mattress pad device 106, and the like to determine a sepsis risk assessment score. Thedata evaluation engine 304 also operates to continuously evaluate data from the electronicmedical record system 108 andhealthcare information systems 110 to determine a sepsis risk assessment score. Thedata evaluation engine 304 uses the model built by themodel building engine 302 to automatically and continuously determine the sepsis risk assessment score. The sepsis risk assessment score predicts whether a patient is likely to develop sepsis. Example methods performed by some embodiments of thedata evaluation engine 304 are illustrated and described in more detail with respect to at leastFIG. 7 . - The
notification engine 306 operate to generate one or more types of notifications to alert caregivers that the patient is likely to develop sepsis when the sepsis risk assessment score exceeds a threshold value, or if the sepsis risk assessment score is classified as a high risk or medium risk. The notification drives early intervention by the caregivers to mitigate the risks and costs associated with sepsis. The notification generated by thenotification engine 306 may be delivered in any suitable form, including audible, visual, and textual such as a text message, pager message, email, or other form of alert, such as a message on theworkstations 112. - The
communications module 308 enables thesepsis monitoring system 200 to communicate with the vital signs monitoring devices including thespot monitor device 102,wearable device 104, andmattress pad device 106, and with the electronicmedical record system 108,healthcare information systems 110, andworkstations 112 in thehealthcare facility 100. Thesepsis monitoring system 200 can communicate with these devices and systems through a wireless connection, a wired connection, or a combination of wireless and wired connections. - The
computing device 1200 processes the data from thedatabase storage 310, and communicates with themodel building engine 302,data evaluation engine 304,notification engine 306, andcommunications module 308. Thecomputing device 1200 includes at least one processor that executes instructions to implement one or more of the methods described herein. -
FIG. 4 illustrates anexample method 400 of providing an early intervention for mitigating the risks and costs associated with sepsis. Referring now toFIG. 4 , themethod 400 atoperation 402 includes determining an initial sepsis risk assessment score for a patient admitted to a healthcare facility. The sepsis risk assessment score predicts a likelihood of the patient developing sepsis while admitted in the facility. The score can be classified as low risk, medium risk, or high risk. Alternatively, the score can be numerical such as based on a scale between 0-100. A sepsis risk assessment model is used to determine the sepsis risk assessment score. - In some examples, the sepsis risk assessment score is displayed in a mobile platform operable on a portable device such as a tablet computer, smartphone, and the like. In addition to, or as an alternative to displaying the sepsis risk assessment score in the mobile platform, the sepsis risk assessment score can also be displayed as an EMR plug-in.
- Next, the
method 400 atoperation 404 includes connecting the patient to at least one vital signs monitoring devices such as a spot monitor device, wearable device, or mattress pad device to continuously measure the vital signs of the patient. - Next, the
method 400 atoperation 406 includes automatically and continuously updating the sepsis risk assessment score for the patient. The sepsis risk assessment model is used to automatically and continuously update the sepsis risk assessment score. - In some embodiments, the sepsis risk assessment score is automatically and continuously updated using the continuously measured vital signs of the patient from at least one of the vital signs monitoring devices, as well as using additional physiological parameters and information from an electronic medical record system. When it is not possible to continuously measure the vital signs of the patient, the sepsis risk assessment score is automatically and continuously updated using data from the electronic medical record system.
- At
operation 408, themethod 400 determines whether the patient is likely to develop sepsis based on the continuously updated sepsis risk assessment score. If the sepsis risk assessment score is less than a threshold value, or if the score is classified as a low risk (i.e., “No” in operation 408), themethod 400 returns to continuously updating the sepsis risk score (i.e., operation 406). If the sepsis risk assessment score exceeds a threshold value, or if the score is classified as a high risk or medium risk (i.e., “Yes” in operation 408), a notification is generated atoperation 410 to alert the caregivers that the patient is likely to develop sepsis. - At
operation 410, a notification is delivered in any suitable form. For example, the notification can include audible, visual, and textual alerts such as text messages, pager messages, emails, or other forms of an alert, such as a message on a display device that is viewable by one or more caregivers. The notification can indicate that a certain action should be taken by a caregiver. For example, the notification can indicate that the caregiver should go check on the patient in-person, confirm the vital signs data, or order a lactate lab. - In some examples, the notification is displayed in a mobile platform operable on a portable device such as a tablet computer, smartphone, and the like. In addition to, or as an alternative to displaying the notification in the mobile platform, the notification is also displayed as an EMR plug-in that is accessible from a workstation.
- At
operation 412, the notification fromoperation 410 drives an early intervention to treat the patient and mitigate the risks and costs associated with sepsis. The early intervention can include providing antibiotics, fluids, taking additional laboratory tests, and other supportive medical interventions. -
FIG. 5 illustrates amethod 500 of building the sepsis risk assessment model for automatically and continuously determining a sepsis risk assessment score that is performed by some embodiments of the model building engine 302 (seeFIG. 3 ). Themethod 500 can be used, for example, to build a model for determining an initial sepsis risk assessment score for a patient admitted to a healthcare facility such as inoperation 402 of the method 400 (seeFIG. 4 ) and also for automatically and continuously updating the sepsis risk assessment score for the patient such as inoperation 406 of themethod 400 described above (seeFIG. 4 ). - At
operation 502, sepsis risk factor data is acquired. The sepsis risk factor data includes vital signs data (e.g., data acquired from at least one of the vital signs monitoring devices ofFIG. 1 ), electronic medical records data (e.g., data acquired from theEMR system 108 ofFIG. 1 ), laboratory data (e.g., data acquired from thelab system 202 ofFIG. 2 ), and admissions data (e.g., data acquired from theADT system 204 ofFIG. 2 ). The sepsis risk factor data is associated with septic patients and with non-septic patients. In some embodiments, thecommunications module 308 of thesepsis monitoring system 200 is utilized to acquire the sepsis risk factor data from the data sources within thehealthcare facility 100. - At
operation 504, the sepsis risk assessment model is built using the acquired sepsis risk factor data. In some embodiments, the sepsis risk assessment model is initially developed using a retrospective analysis of a database that includes the EMR data, lab data, ADT data, and vital signs data. In some embodiments, thedatabase storage 310 of thesepsis monitoring system 200 is utilized to store the EMR data, lab data, ADT data, and vital signs data for performing the retrospective analysis. Themodel building engine 302 of thesepsis monitoring system 200 is utilized to build the sepsis risk assessment model. -
FIG. 6 is a schematic diagram of themodel building engine 302 that receives first and second sets ofinputs risk assessment model 610 as an output. The first set ofinputs 602 include acquired sepsisrisk factor data 604 associated with septic patients. The second set ofinputs 606 include acquired sepsisrisk factor data 608 associated with non-septic patients. In some embodiments, the acquired sepsisrisk factor data model building engine 302 to build the sepsisrisk assessment model 610. - The acquired sepsis
risk factor data 604 can be used as positive training examples while the acquired sepsisrisk factor data 608 can be used as negative training examples to build the sepsisrisk assessment model 610 using one or more machine learning techniques. In some embodiments, the sepsisrisk assessment model 610 is built using supervised machine learning techniques such as a logistic regression. In alternative embodiments, the sepsisrisk assessment model 610 is built using unsupervised machine learning techniques such as neural networks. Also, the sepsisrisk assessment model 610 can be built by tree based methods such as gradient boosting machine learning techniques, and the like. -
FIG. 7 is a schematic diagram of thedata evaluation engine 304. Thedata evaluation engine 304 receives as aninput 702 sepsisrisk factor data 704 for a given patient. Thedata evaluation engine 304 uses the sepsisrisk assessment model 610 to generate as an output a sepsisrisk assessment score 706 that predicts whether the patient is likely to develop sepsis. The sepsisrisk factor data 704 is automatically and continuously evaluated by thedata evaluation engine 304 using the sepsisrisk assessment model 610 to continuously determine the sepsisrisk assessment score 706 while the patient is admitted to the healthcare facility. In certain embodiments, the sepsisrisk assessment score 706 is calculated by the spot monitor 102 ofFIG. 1 . Alternatively, the sepsisrisk assessment score 706 can be calculated by thesepsis monitoring system 200 which is a cloud based system that can connect to thespot monitor 102. - The sepsis
risk factor data 704 includes measured vital signs data including heart rate, respiratory rate, blood pressure, or blood oxygen saturation data. In some further embodiments, the sepsisrisk factor data 704 may also include data such as temperature and mean arterial pressure (MAP), and derived parameters such as shock index (SI) which is an assessment defined as heart rate divided by systolic blood pressure, and estimated cardiac output calculations. In some further embodiments, the sepsisrisk factor data 704 may also include mobility data measured from an accelerometer patch or bed load cell sensors. - In some examples, sepsis
risk assessment score 706 is based on a change over time, a standard deviation, a maximum value, or a difference from a 24 hour moving average in the data. In some examples, the sepsisrisk assessment score 706 is based on a change in heart rate, respiratory rate, blood pressure, or blood oxygen saturation above or below a baseline level. - In some embodiments, the sepsis
risk assessment score 706 is classified in a risk stratification as a low risk, a medium risk, or a high risk. In alternative embodiments, the sepsisrisk assessment score 706 is calculated as a numerical value. - In some examples, in addition to calculating the sepsis
risk assessment score 706, a classifier is generated to identify a trend in the sepsisrisk assessment score 706 such as an increase or decrease in the sepsisrisk assessment score 706. As an illustrative example, the classifier can be a symbol such as an upward arrow to indicate an increasing score and a downward arrow to indicate a decreasing score, or a color such as red to indicate an increasing score and green to indicate a decreasing score. Additionally, the sepsisrisk assessment score 706 can be trended according to mean, minimum, maximum, difference between minimum and maximum, standard deviation, first calculation, last calculation, different between first and last calculation, difference between last calculation and calculation performed 1, 2, 4, 12, 24, or 72 hours ago, frequency of the calculations (i.e., was the calculation taken and how often?). Also, a linear regression trend, a quadratic regression trend, skewness (i.e., a measure of the asymmetry of the probability distribution of a real-valued random variable about its mean), and kurtosis (i.e., a measure of the tails of the probability distribution of a real-valued random variable) can be calculated for analyzing trends in the sepsisrisk assessment score 706. - In some examples, the sepsis
risk assessment score 706 is generated in a manner to prevent alarm fatigue. For example, the sepsisrisk assessment score 706 can be compared to a threshold value specific to the patient (e.g., based upon the patient's prior history) or can be compared to a general threshold value associated with the patient's demographic (e.g., age, sex, etc.). When the sepsis risk assessment score exceeds the threshold value, or if the score is classified as a high risk, a notification is generated by thenotification engine 306 to alert the caregivers that the patient is likely to develop sepsis. The notification drives an early intervention by the caregivers to mitigate the risks and costs associated with sepsis. - In contrast to Systemic inflammatory response syndrome (SIRS), Sequential Organ Failure Assessment (SOFA), and quick SOFA (qSOFA) scores, which are typically calculated every 1 to 4 hours using a limited number of factors, the sepsis
risk assessment score 706 is continuously determined in near-real-time, such as every second, or every five seconds, or every minute, etc. Additionally, by automatically retrieving continuous data from the vital signs monitoring devices, electronicmedical record system 108, andhealthcare information systems 110, the sepsisrisk assessment score 706 is calculated using additional factors not used to calculate the SIRS, SOFA, and qSOFA scores. Therefore, the sepsisrisk assessment score 706 is also more refined and accurate over the SIRS, SOFA, and qSOFA scores which are based only on a limited number of factors. As an illustrative example, the sepsisrisk assessment score 706 is calculated using risk factors including continuous vital signs and physiological data, laboratory data, clinical examination data, medications data, admissions data, and the like. The sepsisrisk assessment score 706 may also be calculated using risk factors such as comorbidities, and recent medical procedures, operations, invasive medical devices, and other patient historical data. In some examples, the sepsisrisk assessment score 706 is calculated using data from point of care devices such as, for example, a handheld blood analyzer that provides real-time measurements for lactate, glucose, procalcitonin, arterial blood gases, and similar parameters. - At least some of the risk factors which contribute to the sepsis
risk assessment score 706 are summarized in Table 1. These risk factors are not exhaustive, and are provided as illustrative examples of the types of data that can be used to calculate the sepsisrisk assessment score 706. -
TABLE 1 Risk Factor 1 Heart rate 2 Heart Rate (Standard Deviation) 3 Heart rate (Max to date) 4 Heart rate (difference from 24-hr moving average) 5 Respiratory Rate 6 Respiratory Rate (Standard Deviation) 7 Respiratory Rate (Max to date) 8 Respiratory Rate (difference from 24-hr moving average) 9 Blood pressure 10 Blood pressure (Standard Deviation) 11 Blood pressure (Max to date) 12 Blood pressure (difference from 24-hr moving average) 13 SpO2 14 SpO2 (Standard Deviation) 15 SpO2 (Max to date) 16 SpO2 (difference from 24-hr moving average) 17 Abdominal pain 18 Abdominal tenderness 19 Abscess 20 Acquired autoimmune disease 21 Active hyperemia 22 Acute lung injury 23 Age 24 Agitation 25 AIDS or HIV 26 Altered mental status 27 Anemia 28 Anxiety 29 Appendicitis 30 Arterial Ph 31 Aspiration 32 Asplenic 33 Autoimmune disease 34 Bacteremia 35 Bicarbonate 36 Bilirubin 37 Bone marrow transplant 38 Cancer 39 Capillary refill time 40 Cardiac output 41 Cellulitis 42 Chemotherapy 43 Cholangitis 44 Cholecystitis 45 Chronic infectious disease 46 Chronic Obstructive Pulmonary Disease 47 Cirrhosis 48 Colitis 49 Compromised cardiac output 50 Congestive heart failure 51 Corticosteriods 52 C-reactive protein 53 Creatinine 54 Cystitis 55 D-dimer 56 Decrease in daily functions 57 Decreased level of consciousness 58 Dehydration 59 Delirium 60 Dementia 61 Diabetes 62 Dialysis 63 Diaphoresis (sweating) 64 Diarrhea 65 Diverticulitis 66 Diverticulosis 67 Dyspnea 68 Encephalitis 69 Encephalopathy 70 Endocarditis 71 Fatigue 72 Fever 73 Gastroenteritis 74 Gastrointestinal bleed 75 Gastrointestinal tract infection 76 Glucose 77 Headache 78 Heart valve disorders 79 Hemaglobin 80 Hematacrit 81 Hyperlactatemia 82 Hypotension 83 Hypothermia 84 Ileus 85 Immunosuppressants 86 Increase in Creatinine 87 Increased pain 88 Inflammatory bowel disease 89 INR 90 IV drug abuse 91 Jaundice 92 Joint replacement 93 Lethargy 94 Leukopenia 95 Malaise 96 Mean arterial pressure 97 Meningitis 98 Mottling of skin 99 Nausea or vomiting (Emesis) 100 Neoplasm 101 Neutropenia 102 Neutrophils (Bands) 103 Nursing home resident 104 Oliguria 105 Organ transplant 106 Osteomyelitis 107 Ostomy 108 PaCO2 109 PaO2 110 PaO2/FiO2 111 Pelvic Pain 112 Peripheral cyanosis 113 Petechial rash 114 Ph 115 Platelets 116 Pneumonia 117 Polydipsia 118 Polyuria 119 Poor tissue perfusion 120 Positive fluid balance 121 Postpartum 122 Pressure injury 123 Procalcitonin 124 Protein in urine 125 PTT 126 Pyelonephritis 127 Recent abortion 128 Recent c-section 129 Recent hospitalization 130 Recent past surgery 131 Recent Prior or Chronic Antibiotics 132 Recent vaginal delivery 133 Renal disease 134 Respiratory infection 135 Seizures 136 Septic arthritis 137 Sickle cell anemia 138 Soft tissue infection 139 Stupor 140 Surgery 141 Syncope 142 Tachycardia 143 Tachypnea 144 Transfer from ICU 145 Trauma 146 White blood cell count 147 Wound -
FIG. 8 illustrates example physical components of acomputing device 1200, such as the computing device or devices used to implement aspects of the disclosure described above. As illustrated, thecomputing device 1200 includes at least one processor or central processing unit (“CPU”) 1208, asystem memory 1212, and asystem bus 1210 that couples thesystem memory 1212 to theCPU 1208. Thecentral processing unit 1208 is an example of a processing device. - The
system memory 1212 includes a random access memory (“RAM”) 1218 and a read-only memory (“ROM”) 1220. A basic input/output system containing the basic routines that help to transfer information between elements within the computing device, such as during startup, is stored in theROM 1220. The computing device further includes amass storage device 1214. Themass storage device 1214 is able to store software instructions and data. Themass storage device 1214 is connected to theCPU 1208 through thesystem bus 1210. - The
mass storage device 1214 and its associated computer-readable data storage media provide non-volatile, non-transitory storage for the computing device. Although the description of computer-readable data storage media contained herein refers to a mass storage device, such as a hard disk or CD-ROM drive, it should be appreciated by those skilled in the art that computer-readable data storage media can be any available non-transitory, physical device or article of manufacture from which the device can read data and/or instructions. Themass storage device 1214 is an example of a computer-readable storage device. - Computer-readable data storage media include volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable software instructions, data structures, program modules or other data. Example types of computer-readable data storage media include, but are not limited to, RAM, ROM, EPROM, EEPROM, flash memory or other solid-state memory technology, CD-ROMs, digital versatile discs (“DVDs”), other optical storage media, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by the computing device.
- The
computing device 1200 may operate in a networked environment using logical connections to remote network devices through anetwork 46, such as a local network, the Internet, or another type of network. Thecomputing device 1200 connects to thenetwork 46 through anetwork interface unit 1216 connected to thesystem bus 1210. Thenetwork interface unit 1216 may also connect to other types of networks and remote computing systems. - The
computing device 1200 includes an input/output unit 1222 for receiving and processing input from a number of other devices, including a touch user interface display screen, or another type of input device. Similarly, the input/output unit 1222 may provide output to a touch user interface display screen, a printer, or other type of output device. - As mentioned above, the
mass storage device 1214 and theRAM 1218 of thecomputing device 1200 can store software instructions and data. The software instructions include anoperating system 1232 suitable for controlling the operation of thecomputing device 1200. Themass storage device 1214 and/or theRAM 1218 also store software instructions, that when executed by theCPU 1208, cause thecomputing device 1200 to provide the functionality discussed in this document, including the methods described herein. - Communication media may be embodied in the software instructions, data structures, program modules, or other data in a modulated data signal, such as a carrier wave or other transport mechanism, and includes any information delivery media. The term “modulated data signal” may describe a signal that has one or more characteristics set or changed in such a manner as to encode information in the signal. By way of example, communication media may include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, radio frequency (RF), infrared, and other wireless media.
- The block diagrams depicted herein are just examples. There may be many variations to these diagrams described therein without departing from the spirit of the disclosure. For instance, components may be added, deleted or modified.
- The description and illustration of one or more embodiments provided in this application are not intended to limit or restrict the scope of the invention as claimed in any way. The embodiments, examples, and details provided in this application are considered sufficient to convey possession and enable others to make and use the best mode of claimed invention. The claimed invention should not be construed as being limited to any embodiment, example, or detail provided in this application. Regardless whether shown and described in combination or separately, the various features (both structural and methodological) are intended to be selectively included or omitted to produce an embodiment with a particular set of features.
- Having been provided with the description and illustration of the present application, one skilled in the art may envision variations, modifications, and alternate embodiments falling within the spirit of the broader aspects of the claimed invention and the general inventive concept embodied in this application that do not depart from the broader scope.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/999,315 US20210059597A1 (en) | 2019-08-30 | 2020-08-21 | Sepsis monitoring system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962893985P | 2019-08-30 | 2019-08-30 | |
US16/999,315 US20210059597A1 (en) | 2019-08-30 | 2020-08-21 | Sepsis monitoring system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210059597A1 true US20210059597A1 (en) | 2021-03-04 |
Family
ID=72517080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/999,315 Pending US20210059597A1 (en) | 2019-08-30 | 2020-08-21 | Sepsis monitoring system |
Country Status (3)
Country | Link |
---|---|
US (1) | US20210059597A1 (en) |
EP (1) | EP3785611A1 (en) |
CN (1) | CN112447289A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022234052A1 (en) * | 2021-05-06 | 2022-11-10 | Koninklijke Philips N.V. | Late-onset neonatal sepsis predictions |
WO2022263459A1 (en) | 2021-06-15 | 2022-12-22 | Neopredix Ag | System and method for the health management within the first 1000 days of life |
EP4290530A1 (en) * | 2022-06-07 | 2023-12-13 | TCC GmbH | Method and prediction system for determining the probability of occurrence of sepsis of a patient |
US11950848B2 (en) | 2020-08-10 | 2024-04-09 | Welch Allyn, Inc. | Fundus imaging for microvascular assessment |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023016909A1 (en) * | 2021-08-12 | 2023-02-16 | Koninklijke Philips N.V. | Method and system for monitoring patients for sepsis following discharge |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110137852A1 (en) * | 2009-11-05 | 2011-06-09 | Ognjen Gajic | Sepsis Monitoring and Control |
US20150025329A1 (en) * | 2013-07-18 | 2015-01-22 | Parkland Center For Clinical Innovation | Patient care surveillance system and method |
US20160292375A1 (en) * | 2013-11-27 | 2016-10-06 | Koninklijke Philips N.V. | Patient monitor and method for monitoring a patient |
US20170147770A1 (en) * | 2015-11-24 | 2017-05-25 | Koninklijke Philips N.V. | Critical care patient monitoring service recommendation using data and text mining techniques |
WO2019025901A1 (en) * | 2017-08-02 | 2019-02-07 | Mor Research Applications Ltd. | Systems and methods of predicting onset of sepsis |
US20190125241A1 (en) * | 2016-04-29 | 2019-05-02 | University Of Virginia Patent Foundation | Method, system, and apparatus for remote patient monitoring or tracking of sepsis-related indicators |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0426982D0 (en) * | 2004-12-09 | 2005-01-12 | Secr Defence | Early detection of sepsis |
KR101595784B1 (en) * | 2013-05-31 | 2016-02-26 | 가톨릭대학교 산학협력단 | Method and system for predicting sepsis risk |
CN109119167B (en) * | 2018-07-11 | 2020-11-20 | 山东师范大学 | Sepsis mortality prediction system based on integrated model |
-
2020
- 2020-08-21 US US16/999,315 patent/US20210059597A1/en active Pending
- 2020-08-25 EP EP20192745.6A patent/EP3785611A1/en active Pending
- 2020-08-28 CN CN202010902431.2A patent/CN112447289A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110137852A1 (en) * | 2009-11-05 | 2011-06-09 | Ognjen Gajic | Sepsis Monitoring and Control |
US20150025329A1 (en) * | 2013-07-18 | 2015-01-22 | Parkland Center For Clinical Innovation | Patient care surveillance system and method |
US20160292375A1 (en) * | 2013-11-27 | 2016-10-06 | Koninklijke Philips N.V. | Patient monitor and method for monitoring a patient |
US20170147770A1 (en) * | 2015-11-24 | 2017-05-25 | Koninklijke Philips N.V. | Critical care patient monitoring service recommendation using data and text mining techniques |
US20190125241A1 (en) * | 2016-04-29 | 2019-05-02 | University Of Virginia Patent Foundation | Method, system, and apparatus for remote patient monitoring or tracking of sepsis-related indicators |
WO2019025901A1 (en) * | 2017-08-02 | 2019-02-07 | Mor Research Applications Ltd. | Systems and methods of predicting onset of sepsis |
Non-Patent Citations (2)
Title |
---|
Garrett P and Seidman J. EMR vs HER – What is the difference? Health IT Buzz. January 4, 2011. (Year: 2011) * |
Guillen, Joseph et al. "Predictive models for severe sepsis in adult ICU patients." 2015 Systems and Information Engineering Design Symposium (2015): 182-187. (Year: 2015) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11950848B2 (en) | 2020-08-10 | 2024-04-09 | Welch Allyn, Inc. | Fundus imaging for microvascular assessment |
WO2022234052A1 (en) * | 2021-05-06 | 2022-11-10 | Koninklijke Philips N.V. | Late-onset neonatal sepsis predictions |
WO2022263459A1 (en) | 2021-06-15 | 2022-12-22 | Neopredix Ag | System and method for the health management within the first 1000 days of life |
EP4290530A1 (en) * | 2022-06-07 | 2023-12-13 | TCC GmbH | Method and prediction system for determining the probability of occurrence of sepsis of a patient |
Also Published As
Publication number | Publication date |
---|---|
EP3785611A1 (en) | 2021-03-03 |
CN112447289A (en) | 2021-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210059597A1 (en) | Sepsis monitoring system | |
JP6704076B2 (en) | Patient risk assessment based on data from multiple sources of healthcare facilities | |
US7395216B2 (en) | Using predictive models to continuously update a treatment plan for a patient in a health care location | |
Muntner et al. | Trends in blood pressure among children and adolescents | |
US20170124279A1 (en) | Adaptive Complimentary Self-Assessment And Automated Health Scoring For Improved Patient Care | |
CN112151172A (en) | Patient risk assessment based on data from multiple sources in a medical facility | |
US20180268938A1 (en) | Systems and methods for providing a user engagement platform to support clinical decisions | |
US11266355B2 (en) | Early warning system and method for predicting patient deterioration | |
US11011274B2 (en) | Method and apparatus for predicting mortality of a patient using trained classifiers | |
WO2018106481A1 (en) | Computer-implemented methods, systems, and computer-readable media for diagnosing a condition | |
US20230116079A1 (en) | Population health platform | |
JP2017174168A (en) | Health management server and health management system | |
US20220139550A1 (en) | Population health platform | |
US20200143917A1 (en) | Systems and methods for monitoring and managing cancer patients risk for acute care utilization and/or for improving treatment tolerability | |
KR20190007609A (en) | Interactive health manigement system and method base on internet of things | |
Bourque et al. | Prevalence and predictors of back-transport closer to maternal residence after acute neonatal care in a regional NICU | |
US20210065856A1 (en) | Patient management based on sensed inputs | |
Scherer et al. | Beyond technology: Can artificial intelligence support clinical decisions in the prediction of sepsis? | |
Chow et al. | The algorithm examining the risk of massive transfusion (ALERT) score accurately predicts massive transfusion at the scene of injury and on arrival to the trauma bay: a retrospective analysis | |
Scales et al. | Predicting time to death after withdrawal of life-sustaining measures using vital sign variability: derivation and validation | |
US20210134435A1 (en) | Behavior modification assistance device, terminal, and server | |
KR20220072775A (en) | Apparatus and method for monitoring and assisting pregnant women | |
US11096580B2 (en) | Adaptive health score | |
US20200035361A1 (en) | Method and electronic device for artificial intelligence (ai)-based assistive health sensing in internet of things network | |
Zhu et al. | Identifying a Clinical Risk Triage Score for Adult Emergency Department |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HILL-ROM SERVICES, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHUNG, CHIEW YUAN;DE BIE, JOHANNES;FITZGIBBONS, STACEY A.;AND OTHERS;SIGNING DATES FROM 20200825 TO 20200901;REEL/FRAME:053662/0655 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: HILL-ROM HOLDINGS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: BARDY DIAGNOSTICS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: VOALTE, INC., FLORIDA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: HILL-ROM, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: WELCH ALLYN, INC., NEW YORK Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: ALLEN MEDICAL SYSTEMS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: HILL-ROM SERVICES, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 Owner name: BREATHE TECHNOLOGIES, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058517/0001 Effective date: 20211213 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |